WO2002046194A3 - Imidazopyridines substituees - Google Patents

Imidazopyridines substituees Download PDF

Info

Publication number
WO2002046194A3
WO2002046194A3 PCT/US2001/046915 US0146915W WO0246194A3 WO 2002046194 A3 WO2002046194 A3 WO 2002046194A3 US 0146915 W US0146915 W US 0146915W WO 0246194 A3 WO0246194 A3 WO 0246194A3
Authority
WO
WIPO (PCT)
Prior art keywords
useful
compounds
substituted imidazopyridines
biosynthesis
induce
Prior art date
Application number
PCT/US2001/046915
Other languages
English (en)
Other versions
WO2002046194A2 (fr
Inventor
Kyle J Lindstrom
Original Assignee
3M Innovative Properties Co
Kyle J Lindstrom
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to UA2003042937A priority Critical patent/UA74593C2/uk
Priority to CA002431040A priority patent/CA2431040A1/fr
Priority to MXPA03005013A priority patent/MXPA03005013A/es
Priority to AU3954702A priority patent/AU3954702A/xx
Priority to SK714-2003A priority patent/SK7142003A3/sk
Priority to HU0600592A priority patent/HUP0600592A2/hu
Priority to BR0116034-6A priority patent/BR0116034A/pt
Priority to EP01987315A priority patent/EP1343783A2/fr
Priority to PL01365739A priority patent/PL365739A1/xx
Priority to KR10-2003-7007533A priority patent/KR20030070048A/ko
Application filed by 3M Innovative Properties Co, Kyle J Lindstrom filed Critical 3M Innovative Properties Co
Priority to IL15588501A priority patent/IL155885A0/xx
Priority to EEP200300273A priority patent/EE200300273A/xx
Priority to NZ526085A priority patent/NZ526085A/xx
Priority to JP2002547931A priority patent/JP2004525868A/ja
Priority to AU2002239547A priority patent/AU2002239547B2/en
Publication of WO2002046194A2 publication Critical patent/WO2002046194A2/fr
Publication of WO2002046194A3 publication Critical patent/WO2002046194A3/fr
Priority to NO20032453A priority patent/NO20032453L/no
Priority to HR20030465A priority patent/HRP20030465A2/hr
Priority to HK04106187A priority patent/HK1063466A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)

Abstract

L'invention concerne des composés d'imidazopyridine renfermant une fonctionnalité amine substituée en position 1. Ces composés sont utiles comme modificateurs de la réponse immune. Les composés et compositions selon l'invention peuvent induire la biosynthèse de différentes cytokines et sont utiles dans le traitement d'une palette de pathologies, notamment des maladies virales et néoplastiques.
PCT/US2001/046915 2000-12-08 2001-12-06 Imidazopyridines substituees WO2002046194A2 (fr)

Priority Applications (18)

Application Number Priority Date Filing Date Title
UA2003042937A UA74593C2 (en) 2000-12-08 2001-06-12 Substituted imidazopyridines
JP2002547931A JP2004525868A (ja) 2000-12-08 2001-12-06 置換イミダゾピリジン類
AU3954702A AU3954702A (en) 2000-12-08 2001-12-06 Substituted imidazopyridines
SK714-2003A SK7142003A3 (en) 2000-12-08 2001-12-06 Substituted imidazopyridines
HU0600592A HUP0600592A2 (en) 2000-12-08 2001-12-06 Substituted imidazopyridines, pharmaceutical compositions containing them and intermediates
BR0116034-6A BR0116034A (pt) 2000-12-08 2001-12-06 Imidazopiridinas substituìdas
EP01987315A EP1343783A2 (fr) 2000-12-08 2001-12-06 Imidazopyridines substituees
IL15588501A IL155885A0 (en) 2000-12-08 2001-12-06 Substituted imidazopyridines
KR10-2003-7007533A KR20030070048A (ko) 2000-12-08 2001-12-06 치환 이미다조피리딘
CA002431040A CA2431040A1 (fr) 2000-12-08 2001-12-06 Imidazopyridines substituees
PL01365739A PL365739A1 (en) 2000-12-08 2001-12-06 Substituted imidazopyridines
EEP200300273A EE200300273A (et) 2000-12-08 2001-12-06 Asendatud imidasopüridiinid
NZ526085A NZ526085A (en) 2000-12-08 2001-12-06 Substituted imidazopyridines
MXPA03005013A MXPA03005013A (es) 2000-12-08 2001-12-06 Imidazopiridinas sustituidas.
AU2002239547A AU2002239547B2 (en) 2000-12-08 2001-12-06 Substituted imidazopyridines
NO20032453A NO20032453L (no) 2000-12-08 2003-05-28 Substituerte imidazopyridiner
HR20030465A HRP20030465A2 (en) 2000-12-08 2003-06-06 Substituted imidazopyridines
HK04106187A HK1063466A1 (en) 2000-12-08 2004-08-18 Substituted imidazopyridines

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25422800P 2000-12-08 2000-12-08
US60/254,228 2000-12-08

Publications (2)

Publication Number Publication Date
WO2002046194A2 WO2002046194A2 (fr) 2002-06-13
WO2002046194A3 true WO2002046194A3 (fr) 2003-02-06

Family

ID=22963437

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/046915 WO2002046194A2 (fr) 2000-12-08 2001-12-06 Imidazopyridines substituees

Country Status (24)

Country Link
EP (1) EP1343783A2 (fr)
JP (1) JP2004525868A (fr)
KR (1) KR20030070048A (fr)
CN (1) CN1249062C (fr)
AR (1) AR035670A1 (fr)
AU (2) AU2002239547B2 (fr)
BR (1) BR0116034A (fr)
CA (1) CA2431040A1 (fr)
CZ (1) CZ20031593A3 (fr)
EE (1) EE200300273A (fr)
HK (1) HK1063466A1 (fr)
HR (1) HRP20030465A2 (fr)
HU (1) HUP0600592A2 (fr)
IL (1) IL155885A0 (fr)
MX (1) MXPA03005013A (fr)
NO (1) NO20032453L (fr)
NZ (1) NZ526085A (fr)
PL (1) PL365739A1 (fr)
RU (1) RU2294934C2 (fr)
SK (1) SK7142003A3 (fr)
TW (1) TWI243819B (fr)
UA (1) UA74593C2 (fr)
WO (1) WO2002046194A2 (fr)
ZA (1) ZA200305238B (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8871782B2 (en) 2003-10-03 2014-10-28 3M Innovative Properties Company Alkoxy substituted imidazoquinolines
US8961477B2 (en) 2003-08-25 2015-02-24 3M Innovative Properties Company Delivery of immune response modifier compounds

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5741908A (en) 1996-06-21 1998-04-21 Minnesota Mining And Manufacturing Company Process for reparing imidazoquinolinamines
UA67760C2 (uk) 1997-12-11 2004-07-15 Міннесота Майнінг Енд Мануфакчурінг Компані Імідазонафтиридин та тетрагідроімідазонафтиридин, фармацевтична композиція, спосіб індукування біосинтезу цитокінів та спосіб лікування вірусної інфекції, проміжні сполуки
US6541485B1 (en) 1999-06-10 2003-04-01 3M Innovative Properties Company Urea substituted imidazoquinolines
US6331539B1 (en) 1999-06-10 2001-12-18 3M Innovative Properties Company Sulfonamide and sulfamide substituted imidazoquinolines
US6756382B2 (en) 1999-06-10 2004-06-29 3M Innovative Properties Company Amide substituted imidazoquinolines
UA75622C2 (en) 2000-12-08 2006-05-15 3M Innovative Properties Co Aryl ether substituted imidazoquinolines, pharmaceutical composition based thereon
US6667312B2 (en) 2000-12-08 2003-12-23 3M Innovative Properties Company Thioether substituted imidazoquinolines
US6664265B2 (en) 2000-12-08 2003-12-16 3M Innovative Properties Company Amido ether substituted imidazoquinolines
US6677348B2 (en) 2000-12-08 2004-01-13 3M Innovative Properties Company Aryl ether substituted imidazoquinolines
US6545016B1 (en) 2000-12-08 2003-04-08 3M Innovative Properties Company Amide substituted imidazopyridines
US6525064B1 (en) 2000-12-08 2003-02-25 3M Innovative Properties Company Sulfonamido substituted imidazopyridines
US20020107262A1 (en) * 2000-12-08 2002-08-08 3M Innovative Properties Company Substituted imidazopyridines
US6660735B2 (en) 2000-12-08 2003-12-09 3M Innovative Properties Company Urea substituted imidazoquinoline ethers
US6664264B2 (en) 2000-12-08 2003-12-16 3M Innovative Properties Company Thioether substituted imidazoquinolines
US6545017B1 (en) 2000-12-08 2003-04-08 3M Innovative Properties Company Urea substituted imidazopyridines
US6677347B2 (en) 2000-12-08 2004-01-13 3M Innovative Properties Company Sulfonamido ether substituted imidazoquinolines
PL210514B1 (pl) 2001-11-29 2012-01-31 3M Innovative Properties Co Preparat farmaceutyczny zawierający modyfikator odpowiedzi immunologicznej
CA2365732A1 (fr) 2001-12-20 2003-06-20 Ibm Canada Limited-Ibm Canada Limitee Etalonnages
JP2005531599A (ja) * 2002-05-29 2005-10-20 スリーエム イノベイティブ プロパティズ カンパニー イミダゾ［４，５−ｃ］ピリジン−４−アミンのための方法
NZ538812A (en) 2002-08-15 2009-02-28 3M Innovative Properties Co Immunostimulatory compositions and methods of stimulating an immune response
JP2006503068A (ja) * 2002-09-26 2006-01-26 スリーエム イノベイティブ プロパティズ カンパニー １ｈ−イミダゾダイマー
EP1590348A1 (fr) 2002-12-20 2005-11-02 3M Innovative Properties Company Imidazoquinoleines a substitution aryle/heteroaryle
US7387271B2 (en) 2002-12-30 2008-06-17 3M Innovative Properties Company Immunostimulatory combinations
JP2006519866A (ja) 2003-03-04 2006-08-31 スリーエム イノベイティブ プロパティズ カンパニー Ｕｖ誘発性の表皮の新形成の予防的治療
CA2518082C (fr) * 2003-03-13 2013-02-12 3M Innovative Properties Company Methodes de diagnostic de lesions de la peau
NZ567227A (en) 2003-03-13 2010-01-29 3M Innovative Properties Co Methods of improving skin quality through topical application of an immune response modifier such as imiquimod
US20040192585A1 (en) 2003-03-25 2004-09-30 3M Innovative Properties Company Treatment for basal cell carcinoma
JP2006522823A (ja) 2003-04-10 2006-10-05 スリーエム イノベイティブ プロパティズ カンパニー 免疫反応調節物質化合物の送達
WO2004110991A2 (fr) 2003-06-06 2004-12-23 3M Innovative Properties Company PROCESSUS DE PREPARATION D'IMIDAZO[4,5-c]PYRIDINE-4-AMINES
EP1653914A4 (fr) 2003-08-12 2008-10-29 3M Innovative Properties Co Composes contenant une structure imidazo a substitution oxime
NZ545412A (en) 2003-08-27 2008-12-24 Coley Pharm Group Inc Aryloxy and arylalkyleneoxy substituted imidazoquinolines
CA2537763A1 (fr) 2003-09-05 2005-03-17 3M Innovative Properties Company Traitement pour le lymphome a cellules b cd5<sp>+</sp>
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
CA2545825A1 (fr) 2003-11-14 2005-06-02 3M Innovative Properties Company Composes d'un anneau d'imidazo substitue par hydroxylamine
CN1906193A (zh) 2003-11-14 2007-01-31 3M创新有限公司 肟取代的咪唑环化合物
MXPA06005910A (es) 2003-11-25 2006-08-23 3M Innovative Properties Co Sistemas de anillo imidazo sustituido y metodos.
US8940755B2 (en) 2003-12-02 2015-01-27 3M Innovative Properties Company Therapeutic combinations and methods including IRM compounds
AU2004312510A1 (en) 2003-12-29 2005-07-21 3M Innovative Properties Company Piperazine, [1,4]diazepane, [1,4]diazocane, and [1,5]diazocane fused imidazo ring compounds
WO2005066170A1 (fr) 2003-12-29 2005-07-21 3M Innovative Properties Company Imidazoquinolines a substitution arylalcenyle et arylalkynyle
JP2007517044A (ja) 2003-12-30 2007-06-28 スリーエム イノベイティブ プロパティズ カンパニー イミダゾキノリニル、イミダゾピリジニル、およびイミダゾナフチリジニルスルホンアミド
AU2005228150A1 (en) 2004-03-24 2005-10-13 3M Innovative Properties Company Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
US8017779B2 (en) 2004-06-15 2011-09-13 3M Innovative Properties Company Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
WO2006065280A2 (fr) 2004-06-18 2006-06-22 3M Innovative Properties Company Composes a noyau imidazo a substitutif d'isoxazole, de dihydroisoxazole et d'oxadiazole
US8026366B2 (en) 2004-06-18 2011-09-27 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
US7897609B2 (en) 2004-06-18 2011-03-01 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
EP1831226B1 (fr) 2004-12-30 2012-08-08 3M Innovative Properties Company Composes chiraux tetracycliques incitant la biosynthese d'interferon
JP5313502B2 (ja) 2004-12-30 2013-10-09 スリーエム イノベイティブ プロパティズ カンパニー 置換キラル縮合［１，２］イミダゾ［４，５−ｃ］環状化合物
US9248127B2 (en) 2005-02-04 2016-02-02 3M Innovative Properties Company Aqueous gel formulations containing immune response modifiers
CA2597587A1 (fr) 2005-02-11 2006-08-17 Coley Pharmaceutical Group, Inc. Composes cycliques imidazo[4,5-c] substitues par oxime et hydroxylamine et procedes associes
JP2008538550A (ja) 2005-04-01 2008-10-30 コーリー ファーマシューティカル グループ，インコーポレイテッド ウイルス感染および腫瘍性疾患を処置するためのサイトカイン生合成の調節因子としての１−置換ピラゾロ（３，４−ｃ）環状化合物
AU2006232377A1 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. Pyrazolopyridine-1,4-diamines and analogs thereof
CA2623541A1 (fr) * 2005-09-23 2007-03-29 Coley Pharmaceutical Group, Inc. Procede de preparation de 1h-imidazo[4,5-c]pyridines et d'analogues de ceux-ci
CN100344325C (zh) * 2005-10-17 2007-10-24 华南师范大学 一种治疗宫颈癌的药物及其制备方法与应用
US7906506B2 (en) 2006-07-12 2011-03-15 3M Innovative Properties Company Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods
WO2009034411A1 (fr) * 2007-09-12 2009-03-19 Centre National De La Recherche Scientifique Perharidines en tant qu'inhibiteurs de cdk
CN112587671A (zh) 2012-07-18 2021-04-02 博笛生物科技有限公司 癌症的靶向免疫治疗
JP6469692B2 (ja) * 2013-12-09 2019-02-13 ユーシービー バイオファルマ エスピーアールエル Ｔｎｆ活性のモジュレーターとしてのイミダゾピリジン誘導体
WO2015103989A1 (fr) 2014-01-10 2015-07-16 Shanghai Birdie Biotech, Inc. Composés et compositions pour l'immunothérapie
TWI691335B (zh) 2014-07-09 2020-04-21 英屬開曼群島商博笛生物科技有限公司 用於治療腫瘤的抗pd-l1組合
CN112546230A (zh) 2014-07-09 2021-03-26 博笛生物科技有限公司 用于治疗癌症的联合治疗组合物和联合治疗方法
CN112546238A (zh) 2014-09-01 2021-03-26 博笛生物科技有限公司 用于治疗肿瘤的抗-pd-l1结合物
CN115350279A (zh) 2016-01-07 2022-11-18 博笛生物科技有限公司 用于治疗肿瘤的抗-her2组合
CN106943596A (zh) 2016-01-07 2017-07-14 博笛生物科技（北京）有限公司 用于治疗肿瘤的抗-cd20组合
CN106943597A (zh) 2016-01-07 2017-07-14 博笛生物科技（北京）有限公司 用于治疗肿瘤的抗-egfr组合
CN118515666A (zh) 2017-04-27 2024-08-20 博笛生物科技有限公司 2-氨基-喹啉衍生物
RU2020102453A (ru) 2017-06-23 2021-07-23 Бирди Байофармасьютикалз, Инк. Фармацевтические композиции

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4689338A (en) * 1983-11-18 1987-08-25 Riker Laboratories, Inc. 1H-Imidazo[4,5-c]quinolin-4-amines and antiviral use
US4929624A (en) * 1989-03-23 1990-05-29 Minnesota Mining And Manufacturing Company Olefinic 1H-imidazo(4,5-c)quinolin-4-amines
US5268376A (en) * 1991-09-04 1993-12-07 Minnesota Mining And Manufacturing Company 1-substituted 1H-imidazo[4,5-c]quinolin-4-amines
US5389640A (en) * 1991-03-01 1995-02-14 Minnesota Mining And Manufacturing Company 1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines
US5494916A (en) * 1993-07-15 1996-02-27 Minnesota Mining And Manufacturing Company Imidazo[4,5-C]pyridin-4-amines
EP0894797A1 (fr) * 1997-01-09 1999-02-03 Terumo Kabushiki Kaisha Nouveaux derives d'amide et intermediaires utilises pour leur synthese
WO1999029693A1 (fr) * 1997-12-11 1999-06-17 Minnesota Mining And Manufacturing Company Imidazonaphthyridines et leur utilisation dans l'activation de la biosynthese de cytokines
WO2000076518A1 (fr) * 1999-06-10 2000-12-21 3M Innovative Properties Company Imidazoquinolines substituees par uree
WO2000076519A1 (fr) * 1999-06-10 2000-12-21 3M Innovative Properties Company Imidazoquinolines substituees sulfonamide et sulfamide
WO2000076505A1 (fr) * 1999-06-10 2000-12-21 3M Innovative Properties Company Imidazoquinolines substituees amides

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4689338A (en) * 1983-11-18 1987-08-25 Riker Laboratories, Inc. 1H-Imidazo[4,5-c]quinolin-4-amines and antiviral use
US4929624A (en) * 1989-03-23 1990-05-29 Minnesota Mining And Manufacturing Company Olefinic 1H-imidazo(4,5-c)quinolin-4-amines
US5389640A (en) * 1991-03-01 1995-02-14 Minnesota Mining And Manufacturing Company 1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines
US5268376A (en) * 1991-09-04 1993-12-07 Minnesota Mining And Manufacturing Company 1-substituted 1H-imidazo[4,5-c]quinolin-4-amines
US5494916A (en) * 1993-07-15 1996-02-27 Minnesota Mining And Manufacturing Company Imidazo[4,5-C]pyridin-4-amines
EP0894797A1 (fr) * 1997-01-09 1999-02-03 Terumo Kabushiki Kaisha Nouveaux derives d'amide et intermediaires utilises pour leur synthese
WO1999029693A1 (fr) * 1997-12-11 1999-06-17 Minnesota Mining And Manufacturing Company Imidazonaphthyridines et leur utilisation dans l'activation de la biosynthese de cytokines
WO2000076518A1 (fr) * 1999-06-10 2000-12-21 3M Innovative Properties Company Imidazoquinolines substituees par uree
WO2000076519A1 (fr) * 1999-06-10 2000-12-21 3M Innovative Properties Company Imidazoquinolines substituees sulfonamide et sulfamide
WO2000076505A1 (fr) * 1999-06-10 2000-12-21 3M Innovative Properties Company Imidazoquinolines substituees amides

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8961477B2 (en) 2003-08-25 2015-02-24 3M Innovative Properties Company Delivery of immune response modifier compounds
US8871782B2 (en) 2003-10-03 2014-10-28 3M Innovative Properties Company Alkoxy substituted imidazoquinolines

Also Published As

Publication number Publication date
AU3954702A (en) 2002-06-18
TWI243819B (en) 2005-11-21
SK7142003A3 (en) 2003-10-07
AU2002239547B2 (en) 2006-11-30
KR20030070048A (ko) 2003-08-27
ZA200305238B (en) 2004-08-27
CZ20031593A3 (cs) 2004-01-14
MXPA03005013A (es) 2003-09-05
IL155885A0 (en) 2003-12-23
CN1249062C (zh) 2006-04-05
EE200300273A (et) 2004-02-16
NO20032453L (no) 2003-07-16
WO2002046194A2 (fr) 2002-06-13
HK1063466A1 (en) 2004-12-31
EP1343783A2 (fr) 2003-09-17
PL365739A1 (en) 2005-01-10
JP2004525868A (ja) 2004-08-26
CN1478090A (zh) 2004-02-25
HRP20030465A2 (en) 2004-06-30
UA74593C2 (en) 2006-01-16
NZ526085A (en) 2004-12-24
RU2003116648A (ru) 2005-02-10
NO20032453D0 (no) 2003-05-28
AR035670A1 (es) 2004-06-23
CA2431040A1 (fr) 2002-06-13
HUP0600592A2 (en) 2006-11-28
BR0116034A (pt) 2004-08-03
RU2294934C2 (ru) 2007-03-10

Similar Documents

Publication Publication Date Title
WO2002046194A3 (fr) Imidazopyridines substituees
WO2002046190A3 (fr) Imidazoquinolines substituees sulfamido ether
WO2003050119A3 (fr) Imidazopyridines a substitution uree
WO2003103584A3 (fr) Imidazopyridines a substitution ether
HK1044488A1 (en) Amide substituted imidazoquinolines
MXPA04005362A (es) Imidazoquinolinas sustituidas con tioeter.
WO2004028539A3 (fr) Dimeres 1h-imidazo
WO2005003065A3 (fr) Imidazo-quinolines a substitution sulfonamide
HK1086762A1 (en) Sulfonamide substituted imidazoquinolines
PL352257A1 (en) Imidazoquinolines substituted by urea
GB2390811B (en) Therapeutic compositions that alter the immune response
GB0514967D0 (en) Therapeutic compositions that alter the immune response

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ CZ DE DE DK DK DM DZ EC EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 155885

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: 526085

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 018198570

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: PA/a/2003/005013

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 1020037007533

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 7142003

Country of ref document: SK

Ref document number: PV2003-1593

Country of ref document: CZ

Ref document number: 2431040

Country of ref document: CA

Ref document number: 1-2003-500487

Country of ref document: PH

Ref document number: 2002547931

Country of ref document: JP

Ref document number: 2002239547

Country of ref document: AU

Ref document number: 890/CHENP/2003

Country of ref document: IN

Ref document number: P20030465A

Country of ref document: HR

WWE Wipo information: entry into national phase

Ref document number: 2003/05238

Country of ref document: ZA

Ref document number: 200305238

Country of ref document: ZA

ENP Entry into the national phase

Ref country code: RU

Ref document number: RU A

WWE Wipo information: entry into national phase

Ref document number: 2001987315

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1020037007533

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 2001987315

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: PV2003-1593

Country of ref document: CZ

WWP Wipo information: published in national office

Ref document number: 526085

Country of ref document: NZ

WWG Wipo information: grant in national office

Ref document number: 526085

Country of ref document: NZ